Cart
sales@molnova.com
TP-353
CAS No. 1253799-29-9
TP-353( EOS-61973 )
Catalog No. M23424 CAS No. 1253799-29-9
TP353 is a CDK7 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 131 | In Stock |
|
| 25MG | 238 | In Stock |
|
| 50MG | 324 | In Stock |
|
| 100MG | 447 | In Stock |
|
| 200MG | 617 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTP-353
-
NoteResearch use only, not for human use.
-
Brief DescriptionTP353 is a CDK7 inhibitor.
-
DescriptionTP353 is a CDK7 inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsEOS-61973
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1253799-29-9
-
Formula Weight531.62
-
Molecular FormulaC35H30FNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1=CC=CC=C1)C2=C(C)C(F)=CC(N(CC3=CC=CC=C3)CC4=CC=CC=C4)=C2OCC5=CC=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Alsteropaullone
Alsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM.
-
Dalpiciclib
Dalpiciclib is a highly selective, orally bioavailable, and comparable potency inhibitor of CDK4 and CKD6 with IC50s of 12.4?nM and 9.9?nM, respectively.
-
Ribociclib succinate
Ribociclib succinate is a highly specific CDK4/6 inhibitor (IC50: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyclin B/CDK1 complex.
